Cel Sci Corporation (CVM)

[Fosco1]

Hi

For what's worth with Cel Sci previsions (eg always wrong) :
"The Company estimates it will incur additional expenses of approximately $6.4 million for the remainder of the Phase 3 clinical trial" (Starting 1st of Jan 2019)

Cash burn : I would say rather 1,7m than 1,2m per month (5M / quarter). Am I wrong M. CPA ???

6.4 M / 1,7 = 3,7 months + 1/1/19 = end of trial : 23 April 2019 !!!

Now, how long can cel sci operate with cash on hand :
8,7 M / 1,7 = 5 months without warrants : end of May.
May be July - August with existing warrants structure, depends on pps.

More cash will be required if no news before October